Cocrystal Pharma's total assets for Q1 2025 were $10.66M, a decrease of -20.79% from the previous quarter. COCP total liabilities were $3.35M for the fiscal quarter, a -14.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.